Previous Section
Review Articles
1. Molecular characterization of acute myeloid leukemia and its impact on treatment.
- Author
- Frankfurt O; Licht JD; Tallman MS;
- Institution
- Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois 60611, USA. o-frankfurt@northwestern.edu
- Journal
- Curr Opin Oncol. 2007 Nov;19(6):635-49.
- Abstract URL
- Click here to view abstract
2. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
- Author
- Valcarcel D; Martino R; Valcarcel D; Martino R;
- Institution
- Division of Clinical Hematology, Hospital de la Sant Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. dvalcarcel@santpau.es
- Journal
- Curr Opin Oncol. 2007 Nov;19(6):660-6.
- Abstract URL
- Click here to view abstract
3. Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
- Author
- Shaw BE; Russell NH;
- Institution
- Section of Haemato-Oncology, Royal Marsden Hospital, Surrey, UK. bshaw@doctors.org.uk
- Journal
- Bone Marrow Transplant. 2008 Mar;41(5):495-503. Epub 2007 Oct 22.
- Abstract URL
- Click here to view abstract
4. Immunotherapy of acute myeloid leukaemia: development of a whole cell vaccine.
- Author
- Cheuk AT; Guinn BA;
- Institution
- Department of Haematological Medicine, King's College London School of Medicine, The Rayne Institute, 123 Coldharbour Lane, London, SE5 9NU, United Kingdom.
- Journal
- Front Biosci. 2008 Jan 1;13:2022-9.
- Abstract URL
- Click here to view abstract
5. Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.
- Author
- Seedhouse C; Russell N;
- Institution
- Department of Academic Haematology, University of Nottingham, Nottingham University Hospitals, Nottingham, UK. claire.seedhouse@nottingham.ac.uk
- Journal
- Br J Haematol. 2007 Jun;137(6):513-29.
- Abstract URL
- Click here to view abstract
6. Monitoring of minimal residual disease in acute myeloid leukemia.
- Author
- Kern W; Haferlach C; Haferlach T; Schnittger S;
- Institution
- MLL Munich Leukemia Laboratory, Munich, Germany. wolfgang.kern@mll-online.com
- Journal
- Cancer. 2008 Jan 1;112(1):4-16.
- Abstract URL
- Click here to view abstract
7. Novel strategies for relapsed and refractory acute myeloid leukemia.
- Author
- Mato AR; Morgans A; Luger SM;
- Institution
- Abramson Cancer Center and Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Journal
- Curr Opin Hematol. 2008 Mar;15(2):108-14.
- Abstract URL
- Click here to view abstract
8. Alternative donor transplants for high-risk acute myeloid leukemia.
- Author
- Gupta V;
- Institution
- Blood and Marrow Transplant Program, Princess Margaret Hospital, University of Toronto, Toronto, Canada. vikas.gupta@uhn.on.ca
- Journal
- Curr Opin Hematol. 2008 Mar;15(2):115-20.
- Abstract URL
- Click here to view abstract
9. New approaches in acute myeloid leukemia.
- Author
- Blum W; Marcucci G;
- Institution
- Division of Hematology and Oncology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. william.blum@osumc.edu
- Journal
- Best Pract Res Clin Haematol. 2008 Mar;21(1):29-41.
- Abstract URL
- Click here to view abstract
10. Consolidation therapy: what should be the standard of care?
- Author
- Rowe JM;
- Institution
- Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Technion, Israel Institute of Technology, Haifa, Israel. rowe@jimmy.harvard.edu
- Journal
- Best Pract Res Clin Haematol. 2008 Mar;21(1):53-60.
- Abstract URL
- Click here to view abstract
